Company page

Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. is a public company traded under the ticker XERS in the American market. The company has a market capitalization of approximately $1.44 billion. Xeris focuses on developing and commercializing innovative therapeutics to improve patient outcomes.

XERS:NASDAQUpdated September 4, 2026
Xeris Biopharma Holdings, Inc. logo
Ticker
XERS:NASDAQ
Asset type
Stock
Market cap
$1.56B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD